Press Releases

Upton Discusses Local Jobs, Multi-Million Dollar Expansion with Pfizer Employees, CEO Ian Read

Leaders also discussed the 21st Century Cures Act, FDA user fee reauthorization, and the need for bipartisan tax reform

f t # e
Kalamazoo, June 6, 2017 | Lynn Turner/Tom Wilbur (202-225-3761/269-385-0039) | comments
U.S. Rep. Fred Upton, R-St. Joseph, today met with members of the Pfizer leadership team and CEO Ian Read to discuss their continued multi-million dollar manufacturing plant expansion in Portage. According to a recent economic impact study, the investment along with ongoing site operations bring in more than $2 billion in economic activity annually and 5,680 jobs to the region. 

“This is truly a great community partnership. I want to commend Pfizer’s leadership for expanding their base right here in Portage. This multi-million dollar investment here at home will mean more good-paying local jobs and improved quality of life for patients across the country,” said Upton. “We also discussed the critical need for bipartisan tax reform to keep this positive growth and job creation going. I was glad to join the leadership team and CEO Ian Read today to learn about the expansion and what we can do at the federal level to continue bringing in these jobs and putting our local manufacturers on a level playing field with the rest of the world.”

Additionally, Upton and the leadership team talked about upcoming legislation to reauthorize the Food and Drug Administration’s (FDA) user fee agreements. H.R. 2430, the FDA Reauthorization Act (FDARA) of 2017 will build on the success of Upton’s 21st Century Cures Act. The legislation is critical for patients, drug and device manufacturers, and the entire health care sector and is seen as a bipartisan, bicameral priority. On Wednesday the Energy and Commerce Committee, of which Upton is a member, is expected to vote on bipartisan legislation.

Learn more about this vote here.

f t # e